Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients. In the fight against severe diseases like cancer, patients often endure a discomforting, weekslong gap between when treatment begins and when doctors can tell if it’s working. The problem often stems from an inability to track the disease’s progression...
